Exozymes Inc: 10% owner Marlett Christopher A received 10,000 shares

What happened

• The Form 4 reports that Marlett Christopher A, a 10% owner, was granted a derivative award of 10,000 shares on Oct 1, 2026. The reported price per share is $0.00 and the total reported value is $0.00.

Key details

• Transaction date: Oct 1, 2026; filing date: Oct 19, 2026. Transaction code: A (award/grant).
• Reported price: $0.00 per share; total reported value: $0.00.
• Shares owned after the transaction: not specified in this Form 4.
• Footnote F1: The option vests in twelve (12) quarterly installments (eleven (11) installments of 833 shares and a final installment of 837 shares) beginning on Dec 31, 2026 and ending on Sep 30, 2029; the option expires on Oct 1, 2033.
• Footnote F2: Shares are held by MDB Capital Holdings, LLC, over which the reporting person has voting and dispositive authority; the reporting person disclaims any interest except to the extent of his pecuniary interests in MDB Capital Holdings, LLC.
• No late filing flag is indicated in the Form 4.

Why it may matter

• This was a grant of a derivative award (option) with a multi-year vesting schedule and a stated expiration date.
• The reporting person is a 10% owner — a large holder, not an executive.
• This filing does not show why the insider traded or why the company acted.